For instance, modulating GATA3 activity in tumor-infiltrating lymphocytes (TILs) could bolster anti-tumor immunity and enhance the efficacy of immune checkpoint inhibitors in GATA3-low cancers [55,56,57]. Here, GATA3 is linked to neoplasm.